US Stock MarketDetailed Quotes

ALKS Alkermes

Watchlist

23.980
-0.670-2.72%

Trading Apr 25 10:23 ET

4.06BMarket Cap11.42P/E (TTM)

Alkermes Stock Forum

Moomoo AI

Mar 7 20:11

Nancy S. Lurker's appointment to Alkermes' Board is viewed positively, bringing deep industry experience and commercial expertise. Her broad skills are expected to drive growth of existing products, portfolio expansion, and new product launches.

Press Release: Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors

Moomoo AI

Feb 15 19:53

Alkermes' surplus of cash over debt and its ability to convert EBIT to free cash flow indicate a conservative balance sheet and low risk in its debt management.

Does Alkermes (NASDAQ:ALKS) Have A Healthy Balance Sheet?

Moomoo AI

Oct 13, 2023 18:48

Although Alkermes' share price has recently dipped, its long-term business trends are positive. Insider purchases, often seen as a good omen by investors, add further optimism.

Alkermes (NASDAQ:ALKS) Shareholders Are Still up 59% Over 3 Years Despite Pulling Back 3.8% in the Past Week

Daedalust

Jun 1, 2021 19:44

Just got FDA approved and have another drug phase1/2 on 4 June!!

$Alkermes(ALKS.US)$

Share Your Today's Profit/Loss

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall